Actinium Pharmaceuticals (NYSE AMERICAN: ATNM) is forging its own pathway in treating underserved diseases. And, for cancer patients, especially those resistant to or untreatable by current regimens and therapeutics, ATNM’s targeted radiotherapies could bring life-saving hope. Moreover, given that a critical component of ATNM’s mission is to commercialize treatments that address urgent unmet medical needs, […]
